You are currently not logged in

Lonza

Biopharmaceutical manufacturing in microbial systems – Gyrolab as an analytical platform supporting process development

D. Schiwek, Global Head of Analytical Development for Microbial and Biopharmaceutical Services

Biopharmaceutical manufacturing in microbial systems – evaluation of Gyrolab as a tool to support process development and subsequent production.

D. Wegman, Head of Quality Control

Dr Wegmann summarizes his experience of using the Gyros immunoassay platform as an alternative method to support process development activities and subsequent production of API’s, with particular regard to method performance and development time.

Cygnus Technologies

Regulatory Compliance in HCP Testing: Attempts to establish standard terminology and best practices

E. Bishop, VP Research and Development

The increased regulatory scrutiny on HCP testing and the need for data driven decisions is outlined by Dr. Eric Bishop.

Conversion of Cygnus Technologies’ HCP and Protein A ELISAs to Gyrolab™ xP workstation: Take flight into the Next Generation

E. Bishop, VP Research and Development

Dr. Bishop presents the HCP and Protein A kits for Gyrolab xP workstations available from Cygnus Technologies.

More information

Application Report 206: Single-system solution for quantification of monoclonal IgG and host cell proteins (HCP)

(PDF, 955.8 kB)

Gyrolab xP workstation

(PDF, 827.8 kB)

Gyrolab Bioaffy CDs and Rexxip buffers

(PDF, 843.9 kB)

Gyros immunoassay platform

See how Gyrolab products and nanoliter-scale technology transform performance and productivity

Develop and run immunoassays at nanoliter scale:

Ready to use on Gyrolab xP workstation

Designed for use with Gyrolab CDs

Login
E-mail:
Password:
Keep me logged in

If you do not have a Gyros website account yet:
request one here.

If you forgot your password:
request a new one.